PulseAugur
EN
LIVE 21:30:28
中文(ZH) 药明康德:以约1.1亿港元回购87.98万股H股

WuXi AppTec Buys Back Shares, Haihe Pharma IPO Accepted

WuXi AppTec announced its repurchase of 879,800 H shares for approximately HK$110 million, at an average price of HK$124.90 per share. The company also noted that Shanghai Haihe Pharmaceutical's IPO application has been accepted by the Shanghai Stock Exchange. The news flash also touched on unrelated topics including AI tool usage during the Gaokao exam, a response from Doubao, a hotel's provision of hidden camera detectors, Samsung's union agreement on compensation, and Pinduoduo's investment in cross-border e-commerce. AI

IMPACT This cluster contains unrelated AI news snippets alongside corporate financial news, making direct AI industry impact assessment difficult.

RANK_REASON Company share buyback and IPO acceptance are significant corporate actions. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Wuxi AppTec: Repurchases 879,800 H shares for approximately HK$110 million

    36氪获悉,药明康德公告,公司当日以均价124.90港元回购87.98万股H股。